Form 4 for CORT CORCEPT THERAPEUTICS INC

Accepted 2022-09-06 00:00:00 ET · period of report 2022-09-01 · accession 0000899243-22-030513 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2022-09-06	2022-09-01	CORT	Guyer William	Chief Development Off	A - Grant	$12.99	+1,844	922	New	+$24.0K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-09-01	A	A	922	$0.00	1,844	D	—	—	(F3) Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements under the Purchase Plan.
2	Common	Common Stock	2022-09-01	A	A	922	$25.98	922	D	—	—	(F1) The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2012 Incentive Award Plan on September 1, 2022. (F2) In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase.